Anticancer Effects and uses of Melatonin: A Review
Journal: Austin Journal of Cancer and Clinical Research (Vol.2, No. 6)Publication Date: 2015-07-29
Authors : Alibek K; Mektepbayeva D; Irving S; Atinbayeva N; Zhaisanbayeva B; Mussurova S; Mussakhan S;
Page : 1-9
Keywords : Melatonin; Cancer treatment; Anti-oxidant; Anti-proliferative; Immunoenhancer;
Abstract
Melatonin (N-acetyl-5-methoxytryptamine, MLT) is a naturally occurring hormone secreted by the pineal gland. Clinical evidence suggests that MLT may have a possible role in the treatment of cancer, where MLT presents many oncostatic properties in a wide variety of tumors, utilizing multiple and converging mechanisms. It is a potent anti-oxidative agent; its circadian rhythm-regulating properties are crucial for orchestrating patterns of hormone secretion, the imbalance of which is implicated in a wide range of hormonedependent cancers of the reproductive organs. Recent advances in cancer treatment can offer therapeutic alternatives that could reduce the severity of unwanted side effects. Several observational studies have demonstrated a relationship between long-term disruption of circadian rhythm with decreased MLT secretion and increased cancer risk, whilst clinical evidence supports the possible benefits from MLT on the survival in patients with a range of cancers. This review will address some of the multiple anticancer properties of MLT, with a particular focus on the mechanisms counteracting tumor occurrence, growth, and development. Recent research into the oncostatic effects of MLT and the mechanisms of action explaining its efficiency for tumor regulation are summarized in this review and suggestions for the therapeutic use of MLT will be presented.
Other Latest Articles
- Reliability of Colposcopic Descriptive Appearances in Oral Pre-Cancers-A Clinico-Patho-Colposcopic Study
- Determination of Combined Effect of pH and Withania somnifera on Human Breast Cancer Cell Line MDAMB- 231
- Coexistence of Monoclonal Gammopathy of Undetermined Significance with Essential Thrombocythemia
- Isolated Skull Metastasis of Ewing’s Sarcoma in a Child
- Personalized Therapy in the Management of Non Small Cell Lung Cancer
Last modified: 2016-07-04 20:14:04